Renu Magdum
Research Subjects
Research Interests
Renu Magdum has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Amod Ahuja
Ophthalmology, Dr. D. Y. Patil Medical College, Hospital & Research Centre, Pune, IND
1 shared publication - Aparna Alapati
Ophthalmology, Dr. D. Y. Patil Medical College, Hospital & Research Centre, Pune, IND
1 shared publication - Ashish Mishra
Department of Ophthalmology, Dr. DY Patil Medical College, Hospital and Research Centre, Sant Tukaram Nagar, Pimpri Colony, Pimpri-Chinchwad, Maharashtra, India
1 shared publication Jhimli Ta
Ophthalmology, Dr. D. Y. Patil Medical College, Hospital, and Research Centre, Pune, IND
1 shared publicationJhimli Ta Jr.
1 shared publicationJohnson S
Community Medicine, Dr.D.Y.Patil Medical College, Hospital and Research Centre, Pune, IND
1 shared publication
Latest Publications
- 1 July 2025
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
A Case Report on use of Topical Insulin Therapy for Persistent Epithelial Defects in Stevens-Johnson Syndrome
Persistent Epithelial Defects (PED) in Stevens-Johnson Syndrome (SJS) pose significant challenges in ophthalmic management. This case highlights the use of topical insulin therapy as a novel treatment for PED in a 59-year-old female with SJS-associated ocular complications. The patient demonstrated significant improvement in visual acuity, a reduction in corneal defect size, and symptomatic relief following topical insulin administration. This report suggests that insulin eye drops may serve as a promising adjunct therapy for PED in patients with SJS.
- 1 July 2025
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
A Case Report on use of Topical Insulin Therapy for Persistent Epithelial Defects in Stevens-Johnson Syndrome
Persistent Epithelial Defects (PED) in Stevens-Johnson Syndrome (SJS) pose significant challenges in ophthalmic management. This case highlights the use of topical insulin therapy as a novel treatment for PED in a 59-year-old female with SJS-associated ocular complications. The patient demonstrated significant improvement in visual acuity, a reduction in corneal defect size, and symptomatic relief following topical insulin administration. This report suggests that insulin eye drops may serve as a promising adjunct therapy for PED in patients with SJS.
- Open Access
- 8 April 2024
- Published by Springer Nature in Cureus
- Vol. 16 (4) , e57817
Morning Glory Anomaly With Serous Macular Detachment
The morning glory (MG) disc anomaly is a congenital excavation of the posterior globe involving the optic disc, with a distinct appearance reminiscent of the MG flower. Various intracranial and ocular associations with MG have been documented. Conditions such as trans-sphenoidal encephalocele and hypoplasia of the intracranial vasculature have been observed in association with this anomaly. In this report, we present a case of MG optic disc anomaly accompanied by serous macular detachment.
- 8 April 2024
- Published by Springer Nature in Cureus
- Vol. 16 (4) , e57817
Open AccessMorning Glory Anomaly With Serous Macular Detachment
The morning glory (MG) disc anomaly is a congenital excavation of the posterior globe involving the optic disc, with a distinct appearance reminiscent of the MG flower. Various intracranial and ocular associations with MG have been documented. Conditions such as trans-sphenoidal encephalocele and hypoplasia of the intracranial vasculature have been observed in association with this anomaly. In this report, we present a case of MG optic disc anomaly accompanied by serous macular detachment.
- Open Access
- 22 March 2022
- Published by Springer Nature in Cureus
- Vol. 14 (3) , e23401
Ocular Surface Diseases in Patients With Diabetes
Diabetes is a major cause of ocular morbidity as multiple mechanisms play a role in inducing inflammatory changes in the eye. Diabetic retinopathy is the most common complication and is well-documented. However, in the era of modern medicine, attention is also being focused on ocular surface changes in diabetes. Therefore, this study aimed to determine the association between diabetes and ocular surface diseases. This is a cross-sectional study examining 320 eyes of 160 patients with diabetes who were grouped according to their duration of diabetes. The symptoms were evaluated using the ocular surface disease index (OSDI) questionnaire. Their recent hemoglobin (Hb) A1c value was recorded. Their external or internal hordeolum, blepharitis, meibomian gland dysfunction, and corneal sensitivity were also evaluated. The tear film was examined using tests, such as Schirmer's test, tear film breakup time (TBUT), tear film meniscus height (TFMH), fluorescein stain, and rose bengal stain. The results were correlated with the duration and control of diabetes. The mean age of the study population was 56.60 years comprising 56% (n=89) females and 44% (n=71) males. The mean OSDI scores were 7.9 ± 3.55 and 57 ± 19.22 in patients without dry eye and with severe dry eye, respectively. The study observed OSDI scores were consistently high with diabetes severity. About 67% (n=24) of patients with HbA1c of >8% had dry eyes. Dry eye was found in 68% (n=59) of patients with the duration of diabetes being >10 years. About 23.7% (n=38) had blepharitis, whereas only 4% (n=7) had external or internal hordeolum and 44% (n=86) had different grades of meibomian gland dysfunction. Corneal sensitivity was abnormal in only 12% (n=12) of patients. About 55% (n=86) of patients had varying degrees of dry eye. A statistically significant correlation was found between the severity of dry eye and TBUT, TFMH values, and grades of corneal staining (P < 0.0001). This study observed that the incidence of dry eyes was found to be higher when patients had uncontrolled diabetes and diabetes for a longer period. The OSDI scoring system is an important diagnostic tool while examining patients with dry eye. In an ophthalmology clinic, patients with diabetes should always be evaluated for any ocular surface changes when being screened for diabetic retinopathy, and proper guidelines should be implemented to detect changes in the ocular surface system as early as possible so that any long-term complications such as infectious or neurotrophic keratitis may be avoided at an early stage.
- 22 March 2022
- Published by Springer Nature in Cureus
- Vol. 14 (3) , e23401
Open AccessOcular Surface Diseases in Patients With Diabetes
Diabetes is a major cause of ocular morbidity as multiple mechanisms play a role in inducing inflammatory changes in the eye. Diabetic retinopathy is the most common complication and is well-documented. However, in the era of modern medicine, attention is also being focused on ocular surface changes in diabetes. Therefore, this study aimed to determine the association between diabetes and ocular surface diseases. This is a cross-sectional study examining 320 eyes of 160 patients with diabetes who were grouped according to their duration of diabetes. The symptoms were evaluated using the ocular surface disease index (OSDI) questionnaire. Their recent hemoglobin (Hb) A1c value was recorded. Their external or internal hordeolum, blepharitis, meibomian gland dysfunction, and corneal sensitivity were also evaluated. The tear film was examined using tests, such as Schirmer's test, tear film breakup time (TBUT), tear film meniscus height (TFMH), fluorescein stain, and rose bengal stain. The results were correlated with the duration and control of diabetes. The mean age of the study population was 56.60 years comprising 56% (n=89) females and 44% (n=71) males. The mean OSDI scores were 7.9 ± 3.55 and 57 ± 19.22 in patients without dry eye and with severe dry eye, respectively. The study observed OSDI scores were consistently high with diabetes severity. About 67% (n=24) of patients with HbA1c of >8% had dry eyes. Dry eye was found in 68% (n=59) of patients with the duration of diabetes being >10 years. About 23.7% (n=38) had blepharitis, whereas only 4% (n=7) had external or internal hordeolum and 44% (n=86) had different grades of meibomian gland dysfunction. Corneal sensitivity was abnormal in only 12% (n=12) of patients. About 55% (n=86) of patients had varying degrees of dry eye. A statistically significant correlation was found between the severity of dry eye and TBUT, TFMH values, and grades of corneal staining (P < 0.0001). This study observed that the incidence of dry eyes was found to be higher when patients had uncontrolled diabetes and diabetes for a longer period. The OSDI scoring system is an important diagnostic tool while examining patients with dry eye. In an ophthalmology clinic, patients with diabetes should always be evaluated for any ocular surface changes when being screened for diabetic retinopathy, and proper guidelines should be implemented to detect changes in the ocular surface system as early as possible so that any long-term complications such as infectious or neurotrophic keratitis may be avoided at an early stage.